Vertex Pharmaceuticals Incorporated vs ZIM Integrated Shipping Services Ltd — how do they compare? Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B), while ZIM Integrated Shipping Services Ltd trades at $24.62 (market cap $2.96B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 45.4× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| VRTX | ZIM | |
|---|---|---|
Market Cap | $134.25B | $2.96B |
Sector | Health | Industrials |
52-Week High | $529.65 | $29.27 |
52-Week Low | $376.62 | $12.44 |
Enterprise Value | $128.37B | $6.81B |
Dividend Yield | — | 20.16% |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →